These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 19190144)

  • 1. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
    Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
    Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
    Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?
    Chalasani N; Crabb DW; Cummings OW; Kwo PY; Asghar A; Pandya PK; Considine RV
    Am J Gastroenterol; 2003 Dec; 98(12):2771-6. PubMed ID: 14687831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
    Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
    J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome.
    Piperno A; Vergani A; Salvioni A; Trombini P; Viganò M; Riva A; Zoppo A; Boari G; Mancia G
    Liver Int; 2004 Oct; 24(5):471-6. PubMed ID: 15482345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
    Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
    Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
    Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
    Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload in nonalcoholic steatohepatitis.
    Fujita N; Takei Y
    Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk factors of fibrosis in nonalcoholic steatohepatitis.
    Fierbinţeanu-Braticevici C; Bengus A; Neamţu M; Usvat R
    Rom J Intern Med; 2002; 40(1-4):81-8. PubMed ID: 15526543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of oxidative stress in non-alcoholic steatohepatitis].
    Mitsuyoshi H; Itoh Y; Okanoue T
    Nihon Rinsho; 2006 Jun; 64(6):1077-82. PubMed ID: 16768112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients.
    Turlin B; Mendler MH; Moirand R; Guyader D; Guillygomarc'h A; Deugnier Y
    Am J Clin Pathol; 2001 Aug; 116(2):263-70. PubMed ID: 11488074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.
    Yamamoto M; Iwasa M; Iwata K; Kaito M; Sugimoto R; Urawa N; Mifuji R; Konishi M; Kobayashi Y; Adachi Y
    J Gastroenterol Hepatol; 2007 Apr; 22(4):498-503. PubMed ID: 17376040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis.
    Thanan R; Murata M; Pinlaor S; Sithithaworn P; Khuntikeo N; Tangkanakul W; Hiraku Y; Oikawa S; Yongvanit P; Kawanishi S
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):518-24. PubMed ID: 18349269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y; Hashimoto E; Yatsuji S; Kaneda H; Taniai M; Tokushige K; Shiratori K
    J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ubiquitin levels in patients with nonalcoholic steatohepatitis.
    Savas MC; Koruk M; Pirim I; Yilmaz O; Karakok M; Taysi S; Yilmaz A
    Hepatogastroenterology; 2003; 50(51):738-41. PubMed ID: 12828075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis.
    Abiru S; Migita K; Maeda Y; Daikoku M; Ito M; Ohata K; Nagaoka S; Matsumoto T; Takii Y; Kusumoto K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
    Liver Int; 2006 Feb; 26(1):39-45. PubMed ID: 16420507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
    Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
    Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.